“…There is also the possibility that some node labels were misidentified and that pathological confirmation could be subject to interobserver variability, though the granular reporting and centralised pathological review of E3311 probably minimised these risks. Patient-level ENE prediction would promote translation to clinical use without reliance on manual segmentation, and work is ongoing to develop autosegmentation tools to facilitate this, 48 , 49 although there are inherent benefits of a node-based model. Above all, node-level prediction greatly denoises the imaging framework space and allows the algorithm to focus on the region where ENE is present.…”